Similar articles

• Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland.

  Wang Q, Zhou JQ, Zhou LM, Chen ZY, Fang ZY, Chen SD, Yang LB, Cai XD, Dai QL, Hong H, Wang HX. Wang Q, et al. Seizure. 2011 Jul;20(6):446-8. doi: 10.1016/j.seizure.2011.02.003. Epub 2011 Mar 11. Seizure. 2011. PMID: 21397523
• Letter: HLA B*1502 allele association with oxcarbamazepine-induced skin reactions in epilepsy patient from India.

  Shankarkumar U, Shah KN, Ghosh K. Shankarkumar U, et al. Epilepsia. 2009 Jul;50(7):1837-8. doi: 10.1111/j.1528-1167.2009.02096.x. Epilepsia. 2009. PMID: 20831525 No abstract available.
• HLA-B*1502 screening in carbamazepine and lamotrigine candidates of Asian background.

  Hassan I. Hassan I. Aust N Z J Psychiatry. 2012 Nov;46(11):1106-7. doi: 10.1177/0004867412455702. Epub 2012 Jul 25. Aust N Z J Psychiatry. 2012. PMID: 22833576 No abstract available.
• Pharmacogenetics of cutaneous adverse drug reactions.

  Aihara M. Aihara M. J Dermatol. 2011 Mar;38(3):246-54. doi: 10.1111/j.1346-8138.2010.01196.x. J Dermatol. 2011. PMID: 21342226 Review.
• Question 2 Should phenytoin and carbamazepine be avoided in Asian populations with the HLA-B*1502 positive genetic variant?

  Ganesan S, Hussain N. Ganesan S, et al. Arch Dis Child. 2011 Jan;96(1):104-6. doi: 10.1136/adc.2010.190454. Arch Dis Child. 2011. PMID: 21169235 Review. No abstract available.